A new perspective on brain derived neurotrophin factor polymorphism in L-dopa induced dyskinesia

J Neurol Neurosurg Psychiatry. 2009 Feb;80(2):129. doi: 10.1136/jnnp.2008.163568.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antiparkinson Agents / adverse effects*
  • Brain-Derived Neurotrophic Factor / cerebrospinal fluid
  • Brain-Derived Neurotrophic Factor / genetics*
  • Corpus Striatum / pathology
  • Dyskinesia, Drug-Induced / etiology*
  • Dyskinesia, Drug-Induced / genetics*
  • Genetic Markers
  • Genotype
  • Humans
  • Levodopa / adverse effects*
  • Neuronal Plasticity / physiology
  • Parkinson Disease / drug therapy
  • Parkinson Disease / pathology
  • Polymorphism, Genetic / genetics*

Substances

  • Antiparkinson Agents
  • Brain-Derived Neurotrophic Factor
  • Genetic Markers
  • Levodopa